Dr David Kerr views a case of engineered T cells in a CRC patient with pulmonary metastases as an example of a single-patient clinical trial, neatly illustrating the potential of precision medicine.
Dr David Kerr views a case of engineered T cells in a CRC patient with pulmonary metastases as an example of a single-patient clinical trial, neatly illustrating the potential of precision medicine.